Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
Location status: Recruiting
NCT Number: NCT07084727
Every pregnancy has a major impact on a woman's heart and blood vessels due to changes required by the body to maintain proper blood flow between mother and foetus. When the placenta does not work properly, preeclampsia can occur. An important first symptom is high blood pressure. Women who have experienced preeclampsia are at higher risk of developing blood pressure and heart problems later on. Therefore, it is very important to detect changes in the blood vessel system so that they can be treated promptly and correctly. We aim to do this by using a new, non-invasive eye test that examines the blood vessels of the retina.
Interested in participating?
Request Info18 year–40 year
Female
Interventional
Not applicable
Edegem, Antwerp, 2650, Belgium
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-invasive test. A blood pressure cuff and tonometer (a type of pen placed on the neck) are used to measure the speed at which a pressure wave propagates from one place to another.
Every time the heart contracts, a pressure wave is generated that propagates from the heart to the blood vessels at a certain speed. The stiffer the blood vessels, the faster the wave propagates.
This study measures the capacity with which blood vessels expand when we briefly cut off blood flow. The endothelium, the inner layer of blood vessels, regulates this expansion. By ultrasound, we measure the difference in diameter of the elbow artery. To cut off the blood flow, we clamp the forearm with a blood pressure cuff for 5 minutes.
When the blood pressure cuff is released, it triggers increased blood flow in the arm, causing the blood vessels to expand. We record this expansion using the above techniques.
Eye imaging measures the capacity with which your blood vessels in the retina can expand in response to a flicker light stimulation.
Time frame: Baseline
Early (retinal) biomarkers for cardiovascular risk in patients with preeclampsia, assessed by DVA.
Contact information is provided by the study sponsor or research team.
University Hospital, Antwerp
Other
Retinal Biomarkers as a Tool for Early Detection of Endothelial Dysfunction in Women With Preeclampsia
Acronym: DAISY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06890013
Acute Coronary Syndrome, Acute Coronary Syndromes
Thessaloniki, Greece
View Trial DetailsNCT07245069
Anthracycline-induced Cardiac Toxicity, Arterial Stiffness
Ljubljana, Slovenia
View Trial DetailsNCT07244809
Adverse Childhood Experience, Endothelial Function (FMD)
Iowa City, Iowa, United States
View Trial DetailsNCT06866119
Adnexal Diseases, Endocrine System Diseases
Boston, Massachusetts, United States
View Trial Details